|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 高血压患者肾素血管紧张素系统阻断的血浆分子标志:肾损害与初发蛋白尿的新预测指标显示文摘蛋白尿是一个与心血管病密切相关的危险因素,也是一般人群的首位死亡原因。虽然已经明确肾素血管紧张素系统(renin-angiotensin system,RAS)阻断剂能延缓高血压患者初发蛋白尿进展、减少蛋白尿排出,但仍不能忽视高血压患者发生初发蛋白尿的比例。 | Baldan-Martin M Mourino-Alvarez L Gonzalez-Calero L Moreno-Luna R Sastre-Oliva T Ruiz-Hurtado G Segura J Lopez JA Vazquez J Vivanco F Alvarez-Llamas G Ruilope LM de la Cuesta F Barderas MG 赵狄 练桂丽 | 2016 | 中华高血压杂志2016，24，6： | 2 |
| 2 | Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study显示文摘 | Alejandro de la Sierra José R. Banegas Julián Segura Manuel Gorostidi Luis M. Ruilope | 2012 | Journal of Hypertension2012，，4： | 2 |
| 3 | 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)显示文摘 | Giuseppe Mancia Guy De Backer Anna Dominiczak Renata Cifkova Robert Fagard Giuseppe Germano Guido Grassi Anthony M Heagerty Sverre E Kjeldsen Stephane Laurent Krzysztof Narkiewicz Luis Ruilope Andrzej Rynkiewicz Roland E Schmieder Harry AJ Struijker Boudi | 2007 | Journal of Hypertension2007，，6： | 2 |
| 4 | 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)显示文摘 | Giuseppe Mancia Guy De Backer Anna Dominiczak Renata Cifkova Robert Fagard Giuseppe Germano Guido Grassi Anthony M Heagerty Sverre E Kjeldsen Stephane Laurent Krzysztof Narkiewicz Luis Ruilope Andrzej Rynkiewicz Roland E Schmieder Harry AJ Struijker Boudi | 2007 | Journal of Hypertension2007，，6： | 2 |
| 5 | Obesity essential hypertension and rennin- angiotensin system显示文摘 | Segura J Ruilope LM | 2007 | Public Health Nutr2007，10，10： | 1 |
| 6 | Ficacy and tolerability of combination therapy with valsartan plus hydrochlorothia-zide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST stady显示文摘 | Ruilope LM Malacco E Khder Y | 2005 | Clln Ther2005，27，5： | 1 |
| 7 | Prognostic Value of Ambulatory Blood Pressure Monitoring in Refractory Hypertension: A Prospective Study显示文摘 | Josep Redon Carlos Campos Maria L. Narciso Jose L. Rodicio Jose M. Pascual Luis M. Ruilope | 1998 | Hypertension1998，，2： | 1 |
| 8 | Antihypertensive treatment in patients with type-2 diabetesmeIlitus: what guidance from recent controlled randomized trials? 显示文摘 | Zanchetti A Ruilope LM | 2002 | J Hypertens2002，20，： | 1 |
| 9 | Microalbuminuria显示文摘 | Segura J Ruilope LM Rodicio JL | 2004 | Clin Exp Hypertens2004，26，： | 1 |
| 10 | Review of blood pressure control rates and outcomes显示文摘 | George Bakris Pantelis Sarafidis Rajiv Agarwal Luis Ruilope | 2013 | Journal of the American Society of Hypertension2013，，： | 1 |
| 11 | Hypertension and obesity:correlates with renin-angiotensin-aldosterone system and uric acid显示文摘 | Ruiz-Hurtado G Ruilope LM | 2014 | J Clin Hypertens(Greenwich)2014，16，8： | 1 |
| 12 | Fieaey and tolerability of combination therapy with valsartan plus hydrochlo rothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors:the VAST study显示文摘 | Ruilope LM Malaeeo E Khder Y | 2005 | Clin Ther2005，27，5： | 1 |
| 13 | Erectile dysfunction in essential arterial hypertension and effects sildenafil: results of Spanish national study 显示文摘 | Aranda P Ruilope LM Cairo C | 2004 | Am J Hypertens2004，17，2： | 1 |
| 14 | Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria显示文摘 | Bakris GL Ruilope LM McMorn SO | | Journal of Hypertension0，，： | 1 |
| 15 | Blood pressure control by the nifedipine GITS–telmisartan combination in patients at high cardiovascular risk: the TALENT study显示文摘 | Giuseppe Mancia Gianfranco Parati Grzegorz Bilo Jasmine Choi Michael Ochan Kilama Luis M Ruilope | 2011 | Journal of Hypertension2011，，3： | 1 |
| 16 | Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) 显示文摘 | Pitt B Bakris G Ruilope LM | 2008 | Circulation2008，118，16： | 1 |
| 17 | Factors influencing the systolic blood pressure response to drug therapy显示文摘 | Campo C Segura J Ruilope LM | 2002 | J Clin Hypertens(Greenwich)2002，4，1： | 1 |
| 18 | A randomized,double blind comparision of the angiotension antagonist,irbesartan,with the full dose range of enalapril for the treatment of mild to moderate hypertension显示文摘 | Mimran A Ruilope L Kerwin L | 1998 | J Hum Hyperten1998，12，3： | 1 |
| 19 | Bloodpressure reduction with LCZ696,a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin:a randomised,double-blind,placebo-controlled,active comparator study显示文摘 | RUILOPE L DUKAT A BHM M | 2010 | Lancet2010，375，： | 1 |
| 20 | Effect of rimonabant, on blood pressure in overweight/obese patients with/without comorbidities: analysis of pooled RIO study results 显示文摘 | Ruilope LM Despres JP Scheen A | 2008 | J Hypertens2008，26，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员